Physician profile
Frederick Carpinter Cobey
NPI 1255401279
$1,443.84
in general payments reported to CMS, 2019-2025
19 companies · $973 in 2025
The $973 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.17 · 2020: $24.83 · 2021: $16.60 · 2022: $47.14 · 2024: $329 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,302.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $286.06 | 2020-2025 | Amplatzer, Amplatzer Amulet |
| Boston Scientific Corporation | $178.66 | 2025 | Watchman Access System |
| Fisher & Paykel Healthcare INC | $115.14 | 2024 | Fisher & Paykel Healthcare |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.57 | 2024-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $83.88 | 2025 | Onpattro, Amvuttra |
| Bridgebio Pharma, INC. | $74.23 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $70.62 | 2025 | Wainua, Farxiga |
| Amgen INC. | $69.20 | 2024-2025 | Repatha |
| Merck Sharp & Dohme LLC | $68.02 | 2024-2025 | Verquvo |
| Abiomed | $64.35 | 2025 | |
| Pfizer INC. | $59.59 | 2024-2025 | |
| Avanos Medical | $53.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.41 | 2024-2025 | Lifevest |
| Novo Nordisk INC | $38.61 | 2021-2022 | |
| Masimo Corporation | $35.01 | 2024 | Set and Rainbow Set |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $29.09 | 2024 | Injectafer |
| Actelion Pharmaceuticals US, INC. | $27.43 | 2025 | Opsumit |
| Regeneron Healthcare Solutions, INC. | $25.13 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Cobey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.